Institution statistics

STICHTING VUMC -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:700-800
Total Number of Projects:700-800
Networking Rank (Reputation):100-200
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):500-600
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 58
As coordinator: 17
As participant: 38
Sole participant: 3
Coordinator / Participant Ratio: 0.45*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 6.293.500 27.981.803 3.542.750 4 4
2019 22.195.201 102.816.842 13.195.174 4 14
2018 6.527.723 4.250.370 2.055.111 2 2
2017 5.407.488 50.188.027 2.853.901 2 4
2016 18.344.566 62.382.604 10.689.862 4 14
2015 7.474.706 0 2.723.128 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
STICHTING VU16
JANSSEN PHARMACEUTICA NV9
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
KAROLINSKA INSTITUTE8
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
KATHOLIEKE UNIVERSITEIT LEUVEN7
ACADEMISCH ZIEKENHUIS GRONINGEN6
NOVARTIS PHARMA6
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE6
UNIVERSITY COLLEGE LONDON6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
KING'S COLLEGE LONDON5
REGION HOVEDSTADEN5
TAKEDA DEVELOPMENT CENTRE EUROPE5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT5
UNIVERSITE DE GENEVE5
UNIVERSITEIT GENT5
UNIVERSITY OF OSLO5
VRIJE UNIVERSITEIT BRUSSEL5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
ELI LILLY AND COMPANY LIMITED4
F HOFFMANNLA ROCHE4
PFIZER LIMITED4
STICHTING LYGATURE4
THE UNIVERSITY OF NOTTINGHAM4
UNIVERSITY OF COPENHAGEN4
UNIVERSITY OF HELSINKI4
UNIVERSITY OF NEWCASTLE UPON TYNE4
UPPSALA UNIVERSITET4
ALZHEIMER EUROPE3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL3
EUROPEAN CANCER PATIENT COALITION3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON3
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA3
H LUNDBECK AS3
MEDIZINISCHE UNIVERSITAET WIEN3
NOVO NORDISK3
PROVINCIA LOMBARDO VENETA ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO FATEBENEFRATELLI3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG3
SVEUCILISTE U SPLITU MEDICINSKI FAKULTET3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACADEMISCH ZIEKENHUIS LEIDEN2
ANAXOMICS BIOTECH S L2
ASTRAZENECA2
ASTRAZENECA AB2
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
CENTRE DE REGULACIO GENOMICA2
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP2
EUREC OFFICE GUG2
EUROPEAN NETWORK OF RESEARCH ETHICS COMMITTEES EV2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GOETEBORGS UNIVERSITET2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HEINRICHHEINEUNIVERSITAET DUESSELDORF2
HELSINGIN YLIOPISTO2
I MAS D Y EMPLEO SERVICONSULTING SL2
INSTITUT CATALA D'ONCOLOGIA2
INSTYTUT MEDYCYNY PRACY IMIENIA PROF DRA MED JERZEGO NOFERA W LODZI2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LEIDEN UNIVERSITY2
LINICAL ACCELOVANCE EUROPE BV2
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE2
MASARYKOVA UNIVERZITA2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MIMETAS BV2
NATIONAL TECHNICAL UNIVERSITY OF ATHENS NTUA2
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO2
OESTERREICHISCHE AGENTUR FUR WISSENSCHAFTLICHE INTEGRITAT2
OULUN YLIOPISTO2
PHILIPPS UNIVERSITAET MARBURG2
PIRKANMAA HOSPITAL DISTRICT2
SANOFIAVENTIS2
SOCIETE EUROPEENNE DE CARDIOLOGIE2
SOFTWARE2
STICHTING KATHOLIEKE UNIVERSITEIT2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
TARTU ULIKOOL2
TECHNISCHE UNIVERSITAET DRESDEN2
THE RESEARCH INSTITUTE OF THE MC GILL UNIVERSITY HEALTH CENTRE2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF MANCHESTER2
TTOPSTART BV2
UNIVERSITA DEGLI STUDI DI GENOVA2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA2
UNIVERSITAET ULM2
Constancy:

Total number of partners:785

Partner loyalty:
Frequent Partner: (> 2 projects): 224
Rare Partner: 561

Frequent / Rare Partner Ratio: 0.4

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2020-06-01Beyond 1M Genomes B1MGparticipant4.000.00028
2020-06-01Chimeric antigen receptor (CAR) T-cell therapy against solid tumors by targeting the vasculature AngioCARcoordinator175.5721
2020-02-01Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells UNPACK PD-L1coordinator175.5721
2020-01-01Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity EarlyCauseparticipant5.997.38114
2020-01-01A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities TO_AITIONparticipant5.990.51514
2020-01-01Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research MATCHcoordinator150.0001
2020-01-01RISK-BASED SCREENING FOR CERVICAL CANCER RISCCcoordinator5.792.35511
2020-01-01EXposome Powered tools for healthy living in urbAN SEttings EXPANSEparticipant11.993.90720
2019-11-01Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis MIRIADEcoordinator4.034.56511
2019-10-01Exploitation of the SECRETory pathway for cancer therapy to address European research SECRETparticipant3.955.33911
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imagecoordinator15.000.00022
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis Host-TBcoordinator2.160.9262
2019-06-01Research and Training in Early Life Nutrition to Prevent Disease GROWTHparticipant2.183.5847
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2019-05-01Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT) DISTINCTparticipant3.998.04810
2019-05-01Saracatinib Trial tO Prevent FOP STOPFOPcoordinator999.7106
2019-03-01European network staff eXchange for integrAting precision health in the health Care sysTems ExACTparticipant1.090.20018
2019-01-01A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health EUCAN-Connectparticipant5.999.70413
2019-01-01automatic detection and localization of High frequency Oscillation in Paediatric Epilepsy HOPEparticipant1.214.40013
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2019-01-01Standard Operating Procedures for Research Integrity SOPs4RIparticipant3.999.86013
2019-01-01CeLac and European consortium for a personalized medicine approach to Gastric Cancer LEGACyparticipant3.577.43111
2019-01-01Identification and Management of Patients at Risk – Outcome and Vascular Events in Peritoneal Dialysis IMPROVE-PDparticipant4.021.38022
2019-01-01Remote Assessment of Disease and Relapse – Alzheimer’s Disease RADAR-ADparticipant4.999.75716
2019-01-01CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease CardioReGenixparticipant14.839.77413
2018-09-01PET Imaging of Alpha-Synuclein Fibril Formation PET-AlphaSyparticipant4.100.37016
2018-06-01Virtue based ethics and Integrity of Research: Train-the-Trainer program for Upholding the principles and practices of the European Code of Conduct for Research Integrity VIRT2UEcoordinator2.800.00014
2018-01-01European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools ELBAcoordinator3.727.72321
2018-01-01An EEG calibration toolkit for monitoring rehabilitation of stroke patients. MRI4DEEGparticipant150.0002
2017-12-01HEAR-ECO Innovative Hearing Aid Research - Ecological Conditions and Outcome Measures HEAR-ECOcoordinator1.637.4884
2017-06-01Implications of Medical Low Dose Radiation Exposure MEDIRADparticipant9.995.14635
2017-05-01Mapping Normative Frameworks for EThics and Integrity of REsearch EnTIREcoordinator3.770.00011
2017-01-01European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment ESCAPE-NETparticipant9.992.88117
2017-01-01Healthy minds from 0-100 years: Optimising the use of European brain imaging cohorts Lifebrainparticipant10.000.00014
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2016-10-01Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 MOPEADparticipant2.043.00015
2016-10-01Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 AMYPADcoordinator11.999.88615
2016-09-01GlioDx - Blood platelet-based monitoring and treatment optimisation for glioblastoma patients GlioDxparticipant150.0002
2016-09-01MicroRNA Isoforms for Molecular Interception of Cervical cancer using Self-samples MIMICSparticipant150.0001
2016-06-01PET Imaging in Drug Design and Development PET3Dparticipant3.901.24810
2016-04-01PRevention Of Malnutrition In Senior Subjects in the EU PROMISSparticipant6.915.50625
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027
2016-03-01Muscle Stress Relief: An integrated research program linking together basic research on secondary myopathies in stress states to innovative translation in applied myology. Muscle stress reliefparticipant1.458.00021
2016-03-01Responding or not responding to training; prediction of balance rehabilitation outcome from structural and functional brain networks in Cerebral Palsy. CP-RehOPcoordinator177.5992
2016-03-01Interdisciplinary Network for Dementia Utilising Current Technology (INDUCT) INDUCTparticipant3.878.75716
2016-01-01PROMOTING MENTAL WELLBEING IN THE AGEING URBAN POPULATION: DETERMINANTS, POLICIES AND INTERVENTIONS IN EUROPEAN CITIES MINDMAPparticipant5.743.16015
2016-01-01Data-driven models for Progression Of Neurological Disease EuroPONDparticipant4.975.8629

overview shows latest 50 from 58 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum